Please assess the completion status of the following clinical trial:

Trial Title: Modulating Effects of Oil Palm Phenolics in Uncontrolled Insulin-treated Type 2 Diabetes Mellitus

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Subject is currently injecting an insulin dosage of \>= 1.0 unit/kilogram/day.~* Subject has a serum glycosylated haemoglobin (HbA1c) \>= 9.~* Subject has fasting plasma glucose level of more than 7.0 mmol/L and less than 12.0 mmol/L.~* Subjects or his/her legally acceptable representative is willing to provide written informed consent.~Exclusion Criteria:~* Subject with diabetic ketoacidosis or in coma.~* Subject with terminal cancer.~* Subject with renal failure (serum creatinine more than 200 umol/L).~* Subject with significant liver impairment (liver function test of 5 times more than the upper limit level).~* Subject with severe dementia and psychosis.~* Subject requires of long term corticosteroid treatment for the underlying disease such as connective tissue disorder.~* Subject with hemoglobinopathy or anemia.~* Subject underwent splenectomy or suffered from splenomegaly.~* Subject with chronic substance abuse such as chronic alcoholism or chronic opiate usage.~* Female subject of childbearing potential unless subject underwent bilateral tubal ligation, bilateral oophorectomy or hysterectomy previously.~* Subject or care giver is unable to perform self-monitoring of capillary blood glucose at home.~* Subject who have been included in any other clinical trial within the previous 3 months.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Oil Palm Phenolics (Type: EXPERIMENTAL): 500 mg gallic acid equivalent (GAE), twice daily, 3 months

Based on this trial design, predict the completion outcome and termination type (if applicable).